Rations reduced for users of anti-obesity medications

On February 19, 2026, reports from Milenio (Mexico) indicate that rations for users of anti-obesity medications have been reduced. This development affects individuals relying on these medications for weight management and could impact public health outcomes related to obesity. The reduction in medication supply may be due to regulatory, supply chain, or budgetary constraints, although specific reasons have not been detailed. The change is significant as it may influence treatment adherence and the broader healthcare system's approach to obesity management in Mexico.